As of April 16, 2025, Phreesia (PHR) has a market cap of $1.41 billion USD. According to our data, Phreesia is ranked No.4533 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.41 B |
-3.71%
|
Dec 31, 2024 | $1.46 B |
8.68%
|
Dec 29, 2023 | $1.35 B |
-28.46%
|
Dec 30, 2022 | $1.88 B |
-22.32%
|
Dec 31, 2021 | $2.42 B |
-23.22%
|
Dec 31, 2020 | $3.15 B |
103.68%
|
Dec 31, 2019 | $1.55 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Allscripts
MDRX
|
$0.45 B |
0.000 M
|
![]() USA
|
![]() McKesson
MCK
|
$86.83 B |
0.003 M
|
![]() USA
|
![]() Teladoc Health
TDOC
|
$1.25 B |
0.000 M
|
![]() USA
|
![]() Veeva Systems
VEEV
|
$36.24 B |
-0.000 M
|
![]() USA
|
![]() Health Catalyst
HCAT
|
$0.26 B |
-0.000 M
|
![]() USA
|
![]() Omnicell
OMCL
|
$1.47 B |
-0.000 M
|
![]() USA
|
![]() Premier
PINC
|
$1.92 B |
0.148 B
|
![]() USA
|
![]() Evolent Health
EVH
|
$1.08 B |
-0.000 M
|
![]() USA
|
Market Cap | = | PHR Stock Price | * | PHR Shares Outstanding |
= | $23.96 | * | 58.77 M | |
= | $1.41 B |